The occurrence of trombocythopathy in CLL patients treated with Ibrutinib

Autor:	K. Chasakova, R. Urbanová, L. Slavik, T. Papajík, D. Starostka, J. Ulehlova, Peter Turcsanyi
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty chemistry.chemical_compound chemistry business.industry Internal medicine Ibrutinib medicine business
Zdroj:	65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
ISSN:	2567-5761
DOI:	10.1055/s-0041-1728148
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::529ae0b13f771a5453b4ddb5645ce6ee https://doi.org/10.1055/s-0041-1728148 Zobrazit plný text záznamu